Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders
Lestaurtinib (CEP701) 是一种 JAK2 抑制剂，可抑制 JAK2/STAT5 信号传导和骨髓增生性疾病患者原代红细胞的增殖
期刊:Blood
影响因子:21
doi:10.1182/blood-2007-04-083402
Elizabeth O Hexner, Cynthia Serdikoff, Mahfuza Jan, Cezary R Swider, Candy Robinson, Shi Yang, Thelma Angeles, Stephen G Emerson, Martin Carroll, Bruce Ruggeri, Pawel Dobrzanski
